Last reviewed · How we verify
Intravenous ondansetron
Intravenous ondansetron is a Small molecule drug developed by Mongi Slim Hospital. It is currently FDA-approved. Also known as: ondansetron.
At a glance
| Generic name | Intravenous ondansetron |
|---|---|
| Also known as | ondansetron |
| Sponsor | Mongi Slim Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy (NA)
- The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery (NA)
- The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology (NA)
- The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery (NA)
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- Dexamethasone vs Ondansetron After Cesarean Delivery (PHASE4)
- Evaluation of Postoperative Pain Control in Ear Surgery (NA)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous ondansetron CI brief — competitive landscape report
- Intravenous ondansetron updates RSS · CI watch RSS
- Mongi Slim Hospital portfolio CI
Frequently asked questions about Intravenous ondansetron
What is Intravenous ondansetron?
Intravenous ondansetron is a Small molecule drug developed by Mongi Slim Hospital.
Who makes Intravenous ondansetron?
Intravenous ondansetron is developed and marketed by Mongi Slim Hospital (see full Mongi Slim Hospital pipeline at /company/mongi-slim-hospital).
Is Intravenous ondansetron also known as anything else?
Intravenous ondansetron is also known as ondansetron.
What development phase is Intravenous ondansetron in?
Intravenous ondansetron is FDA-approved (marketed).
Related
- Manufacturer: Mongi Slim Hospital — full pipeline
- Also known as: ondansetron
- Compare: Intravenous ondansetron vs similar drugs
- Pricing: Intravenous ondansetron cost, discount & access